* Japanese*
Asahikawa Medical College , Faculty of Medicine
2008.03 , Graduated
Asahikawa Medical College , Graduate School, Division of Medical Sciences
Doctor Course , 2015.03 , Completed
Duty , Asahikawa Medical University School of Medicine Medical Course Clinical Medicine - , Assistant Professor , 2023.04 -
Lecture charge , Asahikawa Medical University School of Medicine Medical Course Clinical Medicine - , Visiting Assistant , 2022.04 - 2023.03
University of Chicago , Researcher , 2012.10 - 2014.04
Gastroenterology
English: Shin Otake, Yu Ota, Kazunobu Aso, Mitsuyoshi Okada, Hidemi Hayashi, Takumu Hasebe, Shunsuke Nakajima, Koji Sawada, Mikihiro Fujiya, Toshikatsu Okumura, Contrast-enhanced Ultrasonography Features for Diagnosing Pseudoprogression of Hepatocellular Carcinoma with Immunotherapy: A Case Report of the Response after Pseudoprogression , Internal Medicine , 2023
English: Hidemi Hayashi, Koji Sawada, Hiroki Tanaka, Kazuki Muro, Takumu Hasebe, Shunsuke Nakajima, Toshikatsu Okumura, Mikihiro Fujiya, The effect of heat-killed Lactobacillus brevis SBL88 on improving selective hepatic insulin resistance in non-alcoholic fatty liver disease mice without altering the gut microbiota , Journal of Gastroenterology and Hepatology , 2023 , (IF:4.369)
English: Hidemi Hayashi, Koji Sawada, Takumu Hasebe, Shunsuke Nakajima, Jun Sawada, Yuri Takiyama, Yumi Takiyama, Toshikatsu Okumura, Mikihiro Fujiya, A Successful Case of Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab with Multisystem Immune-related Adverse Events , Internal Medicine , 2022 , (IF:1.271)
English: Takumu Hasebe, Koji Sawada, Mikihiro Fujiya, Submarine volcanic eruption of esophageal varices induced by failed variceal ligation and identified by the gel immersion method , Digestive Endoscopy , 2022 , (IF:7.559)
English: Hiroki Tanaka,Kie Horioka,Takumu Hasebe,Koji Sawada,Shunsuke Nakajima,Hiroaki Konishi,Shotaro Isozaki,Masanori Goto,Yumiko Fujii,Yuki Kamikokura,Katsuhiro Ogawa,Yuji Nishikawa, Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: A novel therapy exploiting tumor-platelet interactions. , International journal of cancer , 2021 , (IF:7.396)
Updated on 2024/03/28
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.